OAKES FRANK R. 4
4 · Stellar Biotechnologies, Inc. · Filed Mar 11, 2019
Insider Transaction Report
Form 4
OAKES FRANK R.
DirectorPresident, CEO & Director
Transactions
- Sale
Common Shares, without par value
2019-03-06$1.25/sh−4,000$5,000→ 47,924 total
Footnotes (1)
- [F1]These shares were sold pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.